109814
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
载药微球经支气管动脉化疗栓塞联合免疫治疗鳞状细胞肺癌病理完全缓解1例
Authors He G, Yang K, Gao Z, Zhang X, Han A
Received 28 August 2024
Accepted for publication 8 December 2024
Published 18 December 2024 Volume 2024:17 Pages 1041—1047
DOI https://doi.org/10.2147/IMCRJ.S491862
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Xudong Zhu
摘要：肺癌是所有肿瘤中发病率最高的，其治疗已成为一个亟待解决的问题。载药微球经支气管动脉化疗栓塞（DEB-BACE）联合免疫治疗是一种罕见的肺癌手术新辅助治疗方法，可显著缩短肺癌患者的手术时间。我们报告一例59岁男性患者，肺鳞癌Ⅲb期伴咯血，在DEB-BACE联合免疫治疗21天后行手术切除，无明显不良事件发生。术后观察到病理完全缓解（pCR），患者恢复良好。DEB-BACE结合免疫治疗可能是局部晚期非小细胞肺癌的新辅助治疗的新选择。
关键词：载药微球经支气管动脉化疗栓塞；免疫治疗；鳞状细胞肺癌